journal article·2022-06-13Open access

Gallium–Strontium Phosphate Conversion Coatings for Promoting Infection Prevention and Biocompatibility of Magnesium for Orthopedic Applications

Ming-Shi Song, Rachel W. Li, Yao Qiu, Si Ming Man, Daniel E. Tuipulotu, Nick Birbilis, Paul N. Smith, Ivan Cole, David L. Kaplan, Xiao-Bo Chen

Abstract

Device-associated infections remain a clinical challenge. The common strategies to prevent bacterial infection are either toxic to healthy mammalian cells and tissue or involve high doses of antibiotics that can prompt long-term negative consequences. An antibiotic-free coating strategy to suppress bacterial growth is presented herein, which concurrently promotes bone cell growth and moderates the dissolution kinetics of resorbable magnesium (Mg) biomaterials. Pure Mg as a model biodegradable material was coated with gallium-doped strontium-phosphate through a chemical conversion process. Gallium was distributed in a gradual manner throughout the strontium-phosphate coating, with a compact structure and a gallium-rich surface. It was demonstrated that the coating protected the underlying Mg parts from significant degradation in minimal essential media at physiological conditions over 9 days. In terms of bacteria culture, the liberated gallium ions from the coatings upon Mg specimens, even though in minute quantities, inhibited the growth of Gram-positiveStaphylococcus aureus, Gram-negative Escherichia coli, andPseudomonas aeruginosa ─ key pathogens causing infection and early failure of the surgical implantations in orthopedics and trauma. More importantly, the gallium dopants displayed minimal interferences with the strontium-phosphate-based coating which boosted osteoblasts and undermined osteoclasts in in vitro co-cultures. This work provides a new strategy to prevent bacterial infection and control the degradation behavior of Mg-based orthopedic implants, while preserving osteogenic features of the devices.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Magnesium Alloys: Properties and Applications · MXene and MAX Phase Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Engineering, RMIT University, Carlton, Victoria 3053, Australia

Trauma and Orthopaedic Research Laboratory, Department of Surgery, The Medical School, The Australian National University, Acton, Canberra, Australian Capital Territory 2601, Australia

Department of Materials Science and Engineering, Monash University, Clayton, Victoria 3800, Australia

Department of Immunology and Infectious Disease, College of Health & Medicine, The Australian National University, Acton, Canberra, Australian Capital Territory 2601, Australia

School of Engineering, College of Engineering and Computer Science, The Australian National University, Acton, Canberra, Australian Capital Territory 2601, Australia

Department of Surgery, The Canberra Hospital, Garran, Australian Capital Territory 2605, Australia

Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, United States

Funding

Australian Research Council

References (73)

Show source-provided references
1. 10.1038/s41579-018-0019-y10.1038/s41579-018-0019-y ↗
2. 10.1002/adma.20200212910.1002/adma.202002129 ↗
3. 10.1016/j.actbio.2016.11.07010.1016/j.actbio.2016.11.070 ↗
4. 10.1002/adhm.20207003910.1002/adhm.202070039 ↗
5. 10.1080/20477724.2019.163207010.1080/20477724.2019.1632070 ↗
6. 10.1016/s0140-6736(10)61458-410.1016/s0140-6736(10)61458-4 ↗
7. 10.1016/j.biomaterials.2013.01.07410.1016/j.biomaterials.2013.01.074 ↗
8. Independent Hospital Pricing Authority (AU). Activity Based Funding Admitted Patient Care 2015-16, Acute Admitted Episodes, Excluding Same Day, 2016.
9. 10.1016/j.jhin.2012.09.00510.1016/j.jhin.2012.09.005 ↗
10. 10.1071/hi1205910.1071/hi12059 ↗
11. 10.1016/j.actbio.2018.10.03610.1016/j.actbio.2018.10.036 ↗
12. 10.1038/nature0212210.1038/nature02122 ↗
13. 10.1016/j.biomaterials.2016.11.04710.1016/j.biomaterials.2016.11.047 ↗
14. 10.1002/adhm.20197000710.1002/adhm.201970007 ↗
15. 10.1016/j.biomaterials.2013.07.08910.1016/j.biomaterials.2013.07.089 ↗
16. 10.1016/j.biomaterials.2014.05.07410.1016/j.biomaterials.2014.05.074 ↗
17. 10.1002/adhm.20170150310.1002/adhm.201701503 ↗
18. 10.1016/j.actbio.2020.12.03010.1016/j.actbio.2020.12.030 ↗
19. 10.1007/s12598-020-01667-z10.1007/s12598-020-01667-z ↗
20. 10.1021/acssuschemeng.9b0519610.1021/acssuschemeng.9b05196 ↗
21. 10.1016/j.biomaterials.2011.02.01310.1016/j.biomaterials.2011.02.013 ↗
22. 10.1002/advs.20170089210.1002/advs.201700892 ↗
23. 10.1002/adhm.20187005010.1002/adhm.201870050 ↗
24. 10.1378/chest.72.4.44210.1378/chest.72.4.442 ↗
25. 10.3389/fcimb.2018.0031610.3389/fcimb.2018.00316 ↗
26. 10.1038/nrd.2018.18610.1038/nrd.2018.186 ↗
27. 10.1002/adma.20210429810.1002/adma.202104298 ↗
28. 10.1007/s10853-014-8782-210.1007/s10853-014-8782-2 ↗
29. 10.1016/j.msec.2019.10992610.1016/j.msec.2019.109926 ↗
30. 10.1016/j.actbio.2008.09.01910.1016/j.actbio.2008.09.019 ↗
31. 10.1016/j.actbio.2012.01.01710.1016/j.actbio.2012.01.017 ↗
32. 10.1016/j.jmbbm.2018.03.04110.1016/j.jmbbm.2018.03.041 ↗
33. 10.1016/j.actbio.2014.01.00410.1016/j.actbio.2014.01.004 ↗
34. 10.1007/s00198-010-1369-010.1007/s00198-010-1369-0 ↗
35. 10.1016/s8756-3282(01)00484-710.1016/s8756-3282(01)00484-7 ↗
36. 10.1016/j.actbio.2013.11.01610.1016/j.actbio.2013.11.016 ↗
37. 10.1016/j.corsci.2019.02.02410.1016/j.corsci.2019.02.024 ↗
38. 10.1002/adhm.20160007410.1002/adhm.201600074 ↗
39. 10.1017/ice.2019.29610.1017/ice.2019.296 ↗
40. 10.1093/jac/dky47710.1093/jac/dky477 ↗
41. 10.1016/j.actbio.2012.03.00910.1016/j.actbio.2012.03.009 ↗
42. Helgason C. D. · 2005 · 290
43. 10.1016/j.actbio.2011.04.01110.1016/j.actbio.2011.04.011 ↗
44. 10.5006/1.356363910.5006/1.3563639 ↗
45. 10.1016/j.actbio.2018.08.03010.1016/j.actbio.2018.08.030 ↗
46. 10.1016/j.actbio.2019.05.06910.1016/j.actbio.2019.05.069 ↗
47. 10.1021/acsami.0c1058410.1021/acsami.0c10584 ↗
48. 10.1016/j.actbio.2021.04.03710.1016/j.actbio.2021.04.037 ↗
49. 10.1016/j.actbio.2020.12.04810.1016/j.actbio.2020.12.048 ↗
50. 10.1038/nmat443510.1038/nmat4435 ↗
51. 10.1016/j.addma.2020.10132110.1016/j.addma.2020.101321 ↗
52. 10.1016/j.actbio.2021.04.05110.1016/j.actbio.2021.04.051 ↗
53. 10.1016/j.actbio.2020.09.02310.1016/j.actbio.2020.09.023 ↗
54. 10.1016/j.surfcoat.2012.12.00510.1016/j.surfcoat.2012.12.005 ↗
55. 10.1016/j.corsci.2021.10958110.1016/j.corsci.2021.109581 ↗
56. 10.1126/scitranslmed.aat752010.1126/scitranslmed.aat7520 ↗
57. 10.3390/jcm1009184210.3390/jcm10091842 ↗
58. 10.1016/j.mser.2014.01.00110.1016/j.mser.2014.01.001 ↗
59. 10.1016/j.actbio.2012.09.01710.1016/j.actbio.2012.09.017 ↗
60. 10.1016/j.jmst.2018.10.00810.1016/j.jmst.2018.10.008 ↗
61. NIST Standard Reference Database 46, NIST Critically Selected Stability Constants of Metal Complexes Database; Texas A&M University: College Station, TX, 2004.
62. 10.1016/j.bone.2016.02.02010.1016/j.bone.2016.02.020 ↗
63. 10.1016/j.bone.2014.07.03310.1016/j.bone.2014.07.033 ↗
64. Swaminathan R. · Clin. Biochem. Rev. · 2003 · 24 · 47
65. 10.1126/science.116080910.1126/science.1160809 ↗
66. 10.1016/j.msec.2020.11128510.1016/j.msec.2020.111285 ↗
67. 10.1038/s41598-021-88058-110.1038/s41598-021-88058-1 ↗
68. 10.1016/j.mattod.2018.05.01810.1016/j.mattod.2018.05.018 ↗
69. 10.1155/2018/921631410.1155/2018/9216314 ↗
70. 10.1111/j.1600-0501.2011.02172.x10.1111/j.1600-0501.2011.02172.x ↗
71. 10.1111/clr.1209710.1111/clr.12097 ↗
72. 10.1016/j.etap.2019.10322010.1016/j.etap.2019.103220 ↗
73. 10.1039/d0en00533a10.1039/d0en00533a ↗